765 research outputs found

    Accommodating the Securities Laws to Employee Benefit Plans

    Get PDF

    Attorney--Client Relationships After Carter and Johnson

    Get PDF

    Reappraisal of Fair Shares In Controlled Mergers

    Get PDF

    The Corporate and Securities Adviser, The Public Interest, and Professional Ethics

    Get PDF
    It is the thesis of this Article that we, as a society, need to make deliberate decisions about the proper role of the corporate adviser, and, when that function has been defined, to develop a structure within which it can be performed. As the Article makes clear, the logical choices involve what might be described as either revolutionary change or reactionary change. That is, the current trends should either be accelerated or reversed; the present situation is intolerable. While the author will contend that the case for shifting into reverse is more persuasive, getting into a gear, and out of the current neutral drift, is probably more important than the selection of the appropriate gear. The specific question to which much of this Article is addressed is whether the corporate adviser\u27s present--or at least recently past--role as confidant of management, exercising independent judgment and moral suasion to affect client behavior, should be changed, as it is now changing, to a function autonomous of management, with primary loyalty to the general public. The development of that public function is probably most apparent in the treatment of securities lawyers, and it is upon them that the Article will focus. It should be obvious, however, that the factors influencing the role of the securities law adviser eventually will also affect the tax lawyer, the antitrust adviser, the estate planner, and all other practitioners whose function is advisory rather than adversary in nature. Whatever role it is that we desire corporate advisers to fill, there is a desperate need for a new Code to reflect their appropriate duties; that, too, is given attention in this Article

    The SEC and Corporate Disclosure: Regualtion in Search of a Purpose

    Get PDF
    A Book Notice about The SEC and Corporate Disclosure: Regulation in Search of a Purpose by Homer Kripk

    Current Trends in International Securities Regulation

    Get PDF

    The SEC and Corporate Disclosure: Regualtion in Search of a Purpose

    Get PDF

    A Note on Corporate America

    Get PDF
    A Review of The Attack on Corporate America: The Corporate Issues Sourcebook edited by M. Bruce Johnso

    First record of Penthalodes ovalis (Dugès, 1834) in agricultural area with notes on its pest status (Acari: Penthalodidae)

    Get PDF
    The first record of species Penthalodes ovalis (Dugès, 1834) in agricultural habitat is presented in this paper. This is also the first record of the occurrence and damages on grown plants. The variability of the morphology and new data on the biology are given as well

    Role of chondroitin sulfate proteoglycans (CSPGs) in synaptic plasticity and neurotransmission in mammalian spinal cord.

    Get PDF
    Chronic unilateral hemisection (HX) of the adult rat spinal cord diminishes conduction through intact fibers in the ventrolateral funiculus (VLF) contralateral to HX. Intraspinal injections of Chondroitinase-ABC, known to digest chondroitin sulfate proteoglycans (CSPGs) in the vicinity of injury, prevented this decline of axonal conduction. This was associated with improved locomotor function. We further injected three purified CSPGs into the lateral column of the uninjured cord at T10: NG2 and neurocan, which increase in the vicinity of a spinal injury, and aggrecan, which decreases. Intraspinal injection of NG2 acutely depressed axonal conduction through the injection region in a dose dependent manner. Similar injections of saline, aggrecan, or neurocan had no significant effect. These results identify a novel acute action of CSPGs on axonal conduction in spinal cord, and suggest that antagonism of proteoglycans reverses or prevents the decline of axonal conduction, in addition to stimulating axonal growth
    • …
    corecore